Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1969 1
1971 1
1972 2
1973 1
1976 1
1977 1
1979 1
1980 1
1984 1
1985 4
1987 1
1988 2
1989 2
1990 1
1991 2
1992 1
1993 3
1994 4
1995 3
1996 6
1997 5
1998 4
1999 2
2000 6
2001 15
2002 14
2003 20
2004 18
2005 18
2006 23
2007 29
2008 53
2009 39
2010 45
2011 76
2012 96
2013 94
2014 105
2015 167
2016 173
2017 162
2018 200
2019 226
2020 257
2021 308
2022 360
2023 371
2024 164

Text availability

Article attribute

Article type

Publication date

Search Results

2,743 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3).
Shi Y, Wu L, Yu X, Xing P, Wang Y, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y, Yuan Y, Feng J, Chen Z, Shi J, Sun T, Wu G, Shu Y, Guo Q, Zhang Y, Song Y, Zhang S, Chen Y, Li W, Niu H, Hu W, Wang L, Huang J, Zhang Y, Cheng Y, Wu Z, Peng B, Sun J, Mancao C, Wang Y, Sun L. Shi Y, et al. Among authors: niu h. Cancer Commun (Lond). 2022 Dec;42(12):1314-1330. doi: 10.1002/cac2.12385. Epub 2022 Nov 6. Cancer Commun (Lond). 2022. PMID: 36336841 Free PMC article. Clinical Trial.
Alteration of Gut Microbiota in Individuals at High-Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance.
Luo Y, Tong Y, Wu L, Niu H, Li Y, Su LC, Wu Y, Bozec A, Zaiss MM, Qing P, Zhao H, Tan C, Zhang Q, Zhao Y, Tang H, Liu Y. Luo Y, et al. Among authors: niu h. Arthritis Rheumatol. 2023 Oct;75(10):1736-1748. doi: 10.1002/art.42616. Epub 2023 Sep 21. Arthritis Rheumatol. 2023. PMID: 37219936
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2).
Ou SI, Nishio M, Ahn MJ, Mok T, Barlesi F, Zhou C, Felip E, de Marinis F, Kim SW, Pérol M, Liu G, Migliorino MR, Kim DW, Novello S, Bearz A, Garrido P, Mazieres J, Morabito A, Lin HM, Yang H, Niu H, Zhang P, Kim ES. Ou SI, et al. Among authors: niu h. J Thorac Oncol. 2022 Dec;17(12):1404-1414. doi: 10.1016/j.jtho.2022.08.018. Epub 2022 Sep 10. J Thorac Oncol. 2022. PMID: 36096442 Free article.
H2S-based fluorescent imaging for pathophysiological processes.
Jia TT, Zhang Y, Hou JT, Niu H, Wang S. Jia TT, et al. Among authors: niu h. Front Chem. 2023 Jan 27;11:1126309. doi: 10.3389/fchem.2023.1126309. eCollection 2023. Front Chem. 2023. PMID: 36778034 Free PMC article. Review.
MARK3 kinase: Regulation and physiologic roles.
Yang J, Niu H, Pang S, Liu M, Chen F, Li Z, He L, Mo J, Yi H, Xiao J, Huang Y. Yang J, et al. Among authors: niu h. Cell Signal. 2023 Mar;103:110578. doi: 10.1016/j.cellsig.2022.110578. Epub 2022 Dec 26. Cell Signal. 2023. PMID: 36581219 Review.
2,743 results